Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in DO NOT EDIT

2 clinical trials in DO NOT EDIT, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

GreeceOur site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)
DO NOT EDIT at a glance
2
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in DO NOT EDIT

Open in trial search

Partial seizures

Not yet recruiting

Long‑Term Safety and Effectiveness of 3-(7‑chloro‑1H‑indazol‑5‑yl)-2,5‑bis(trifluoromethyl)-3H‑imidazo[4,5‑b]pyridine in Adults with Refractory Focal Onset Epilepsy

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Rapport Therapeutics Inc.

Study of dapirolizumab pegol placental transfer to infants in pregnant women with active systemic lupus erythematosus (drug combination)

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years
  • Substances:Benzocaine
  • Sponsor:UCB Biopharma

Other cities in Greece

The busiest research cities in the country

All 48 cities in Greece

Clinical research in DO NOT EDIT

What the registry says about research in the country

01 Nervous System Diseases

Clinical research in the city targets Epilepsy, aiming to test innovative therapies that could reduce seizure frequency and enhance patient safety.

  • Long‑term safety and tolerability of RAP‑219 in adults with refractory focal seizures
  • Evaluation of novel anti‑epileptic agents for focal onset seizures
  • Assessment of quality‑of‑life outcomes in participants receiving new seizure‑control treatments
  • Monitoring of neurological function during extended treatment periods

The recruiting trial sites are actively enrolling participants, offering patients access to cutting‑edge seizure management strategies in this European hub.

02 Immune System Processes

Investigations focus on Systemic lupus erythematosus (SLE) in pregnant women, assessing how therapy may cross the placenta and affect newborn health.

  • Transfer dynamics of dapirolizumab pegol from mother to infant during active SLE
  • Safety profiling of infants exposed to maternal biologic therapy in utero
  • Long‑term follow‑up of child development after prenatal exposure
  • Evaluation of maternal disease control while maintaining fetal safety

Both studies are currently recruiting, providing a valuable opportunity for patients to contribute to advancements in autoimmune disease management during pregnancy.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.